UK markets closed

NIKKEI 225
38,073.98
-128.42(-0.34%)
HANG SENG
18,537.81
+223.91(+1.22%)
CRUDE OIL
79.66
+0.40(+0.50%)
GOLD FUTURES
2,352.80
+12.50(+0.53%)
DOW
39,387.76
+331.36(+0.85%)
Bitcoin GBP
50,593.50
+1,702.98(+3.48%)

Best UK mortgage deals of the week

As Bank of England holds interest rates, here's what high street banks are offering home buyers

SAGE Jan 2026 32.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

2.9000

0.0000

(0.00%)

As of 12:50PM EDT. Market open.

Business Wire
Sage Therapeutics to Participate in Upcoming May Investor Conferences
CAMBRIDGE, Mass., May 07, 2024--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will participate in the following upcoming investor conferences in May:
Insider Monkey
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript
Sage Therapeutics, Inc. (NASDAQ:SAGE) Q1 2024 Earnings Call Transcript April 25, 2024 Sage Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.8 EPS, expectations were $-1.63. Sage Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, […]
Simply Wall St.
Earnings Update: Sage Therapeutics, Inc. (NASDAQ:SAGE) Just Reported And Analysts Are Boosting Their Estimates
Investors in Sage Therapeutics, Inc. ( NASDAQ:SAGE ) had a good week, as its shares rose 2.7% to close at US$13.69...